Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
TIANDA PHARMA (00455)
- 0.091
- 0.0000.00%
Market Closed May 15 09:00 CST
195.65MMarket Cap-2.76P/E (TTM)
0.000High0.000Low0Volume0.091Open0.091Prev Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.15BShares0.21552wk High0.43P/B195.65MFloat Cap0.08552wk Low--Dividend TTM2.15BShs Float1.980Historical High--Dividend LFY0.00%Range %0.085Historical Low--Avg Price2000Lot Size--Div Yield TTM--Div Yield LFY
TIANDA PHARMA (00455) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -27.58%-69.33M | ---- | -111.49%-54.34M | ---- | 46.35%-25.69M | ---- | -74.52%-47.89M | ---- | -272.29%-27.44M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 65.09%-384K | ---- | 63.72%-1.1M | ---- | 6.94%-3.03M | ---- | -0.73%-3.26M | ---- | 38.89%-3.23M | ---- |
| Impairment and provisions: | 2,222.62%14.07M | ---- | -626.19%-663K | ---- | -98.01%126K | ---- | 22,028.79%6.34M | ---- | -100.96%-28.93K | ---- |
| -Impairmen of inventory (reversal) | -66.01%-674K | ---- | 73.82%-406K | ---- | -126.81%-1.55M | ---- | --5.79M | ---- | ---- | ---- |
| -Impairment of goodwill | 1,002.46%14.76M | ---- | --1.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | 99.06%-15K | ---- | -195.17%-1.6M | ---- | 200.54%1.68M | ---- | 2,028.79%558K | ---- | -120.96%-28.93K | ---- |
| Revaluation surplus: | 86.34%-87K | ---- | -163.70%-637K | ---- | --1M | ---- | ---- | ---- | ---1.18M | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --85.78K | ---- |
| -Other fair value changes | 86.34%-87K | ---- | -163.70%-637K | ---- | --1M | ---- | ---- | ---- | ---1.26M | ---- |
| Asset sale loss (gain): | 6.80%110K | ---- | 173.05%103K | ---- | 84.90%-141K | ---- | -1,361.70%-934K | ---- | 2.40%74.03K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 6.80%110K | ---- | 173.05%103K | ---- | 84.90%-141K | ---- | -1,361.70%-934K | ---- | 2.40%74.03K | ---- |
| Depreciation and amortization: | 1.10%38.65M | ---- | 5.01%38.23M | ---- | -3.40%36.41M | ---- | 82.79%37.69M | ---- | 5.62%20.62M | ---- |
| -Amortization of intangible assets | 26.43%3.65M | ---- | 22.12%2.89M | ---- | -83.31%2.36M | ---- | 140.43%14.16M | ---- | 32.58%5.89M | ---- |
| Financial expense | -27.21%3.53M | ---- | -1.86%4.85M | ---- | -1.92%4.95M | ---- | 785.75%5.04M | ---- | 52.26%569.35K | ---- |
| Special items | 390.00%261K | ---- | 89.05%-90K | ---- | -34.98%-822K | ---- | -266.19%-609K | ---- | 95.32%-166.31K | ---- |
| Operating profit before the change of operating capital | 3.47%-13.17M | ---- | -206.65%-13.64M | ---- | 453.61%12.79M | ---- | 66.46%-3.62M | ---- | -135.87%-10.79M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -108.24%-1.94M | ---- | 224.36%23.5M | ---- | -231.02%-18.9M | ---- | 226.69%14.43M | ---- | -287.71%-11.39M | ---- |
| Accounts receivable (increase)decrease | -83.05%4.44M | ---- | -23.89%26.21M | ---- | 377.49%34.44M | ---- | 72.48%-12.41M | ---- | -129.88%-45.1M | ---- |
| Accounts payable increase (decrease) | 177.55%27.33M | ---- | 55.22%-35.25M | ---- | -175.35%-78.7M | ---- | 150.25%104.45M | ---- | 412.53%41.74M | ---- |
| prepayments (increase)decrease | 120.49%635K | ---- | -94.45%288K | ---- | 124.64%5.19M | ---- | -164.49%-21.07M | ---- | -23.71%-7.97M | ---- |
| Cash from business operations | 1,452.02%17.31M | ---- | 102.47%1.12M | ---- | -155.25%-45.18M | ---- | 344.13%81.78M | ---- | -172.64%-33.5M | ---- |
| China income tax paid | 104.43%264K | ---- | -1,701.88%-5.96M | ---- | 220.39%372K | ---- | 91.34%-309K | ---- | 50.74%-3.57M | ---- |
| Interest paid - operating | 27.21%-3.53M | ---- | 1.86%-4.85M | ---- | 1.92%-4.95M | ---- | -785.75%-5.04M | ---- | -52.26%-569.35K | ---- |
| Special items of business | ---- | 182.52%24.44M | ---- | 44.40%-29.62M | ---- | ---53.28M | ---- | -7.73%-25.59M | ---- | 23.59%-23.75M |
| Net cash from operations | 244.73%14.04M | 182.52%24.44M | 80.51%-9.7M | 44.40%-29.62M | -165.10%-49.76M | ---53.28M | 303.08%76.43M | -7.73%-25.59M | -89.10%-37.63M | 23.59%-23.75M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -65.09%384K | -66.37%267K | -63.72%1.1M | -58.67%794K | -6.94%3.03M | --1.92M | 0.73%3.26M | -31.97%1.22M | -38.89%3.23M | -36.90%1.79M |
| Sale of fixed assets | ---- | ---- | -68.55%89K | -99.57%1K | -76.86%283K | --234K | 36,008.65%1.22M | --29.35K | 29.87%3.39K | ---- |
| Purchase of fixed assets | 54.81%-11.62M | -9.10%-7.72M | 47.40%-25.72M | 81.85%-7.08M | -100.52%-48.9M | ---39.01M | 82.87%-24.39M | 63.35%-21.21M | -51.57%-142.39M | -69.93%-57.87M |
| Purchase of intangible assets | 46.75%-8.99M | 84.81%-1.24M | 0.72%-16.88M | -2,133.42%-8.15M | ---17M | ---365K | ---- | ---- | 90.89%-765.8K | ---636.61K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---30.42M |
| Recovery of cash from investments | -59.64%41.09M | -69.73%22.92M | -66.09%101.83M | -52.44%75.71M | 165.17%300.28M | --159.19M | -57.91%113.24M | -14.02%103.4M | -55.80%269.05M | --120.25M |
| Cash on investment | 55.52%-41.01M | 64.48%-28.8M | 69.91%-92.19M | 57.18%-81.09M | -199.31%-306.41M | ---189.39M | 61.16%-102.37M | 10.40%-103.46M | 52.31%-263.57M | ---115.47M |
| Other items in the investment business | ---- | ---- | ---- | ---- | 33.57%-380K | ---380K | 82.66%-572K | -243.92%-3.49M | ---3.3M | 99.68%-1.01M |
| Net cash from investment operations | 36.61%-20.14M | 26.46%-14.58M | 54.02%-31.78M | 70.76%-19.82M | -619.20%-69.1M | ---67.8M | 93.02%-9.61M | 71.79%-23.52M | -235.40%-137.73M | -387.74%-83.37M |
| Net cash before financing | 85.28%-6.11M | 119.95%9.87M | 65.11%-41.47M | 59.16%-49.44M | -277.88%-118.86M | ---121.07M | 138.10%66.82M | 54.16%-49.11M | -187.64%-175.37M | -4,974.73%-107.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 49.34%113.38M | 154.46%69.31M | 74.70%75.92M | 692.98%27.24M | 169.04%43.46M | --3.44M | -85.40%16.15M | -58.44%17.66M | 429.18%110.61M | --42.49M |
| Refund | -31.48%-124.79M | -107.61%-77.99M | -47.37%-94.92M | -26.33%-37.57M | -170.24%-64.41M | ---29.74M | -316.65%-23.83M | ---- | ---5.72M | ---- |
| Dividends paid - financing | ---- | ---- | 0.00%-5.59M | ---2.42M | 68.30%-5.59M | ---- | -86.12%-17.63M | 46.68%-5.05M | 43.09%-9.47M | 43.12%-9.47M |
| Absorb investment income | --150K | ---- | ---- | ---- | ---- | ---- | --90K | ---- | ---- | ---- |
| Other items of the financing business | --776K | ---- | ---- | ---- | ---25.23M | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 50.53%-15.16M | 29.00%-11.11M | 46.60%-30.65M | 46.18%-15.65M | -98.66%-57.39M | ---29.09M | -131.83%-28.89M | -65.36%10.53M | 11,274.89%90.75M | 257.64%30.41M |
| Effect of rate | 108.35%387K | 140.18%1.94M | -192.61%-4.63M | -946.10%-4.83M | 95.00%-1.58M | ---462K | -251.47%-31.66M | -62.62%4.28M | 207.58%20.9M | 160.37%11.44M |
| Net Cash | 70.51%-21.27M | 98.08%-1.25M | 59.08%-72.12M | 56.65%-65.1M | -564.68%-176.25M | ---150.16M | 144.83%37.93M | 49.72%-38.57M | -36.96%-84.61M | -258.46%-76.71M |
| Begining period cash | -47.25%85.69M | -47.25%85.69M | -52.26%162.44M | -52.26%162.44M | 1.88%340.28M | --340.28M | 7.06%334M | -20.42%248.25M | -20.65%311.96M | -20.65%311.96M |
| Cash at the end | -24.37%64.81M | -6.63%86.38M | -47.25%85.69M | -51.22%92.51M | -52.26%162.44M | --189.65M | 37.07%340.28M | -13.27%213.95M | -20.42%248.25M | -30.08%246.69M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -31.67%234.71M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"